Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300454
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,121
Award facts
- Contract value 100% obligated
- $3,120.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
About this award
Lonza Walkersville, Inc., a foreign-owned manufacturer of biological materials and laboratory equipment, was awarded a BPA call valued at approximately $3.1K under a Firm Fixed Price contract by the Office of the Director (a civilian federal agency) on January 30, 2015. This contract, which was completed by December 31, 2015, was executed without a set-aside designation, indicating open competition. The work was performed at Lonza Walkersville's facility in Walkersville, Maryland, and falls under the broader category of drugs and biologicals procurement.
This award represents a task order call against Lonza Walkersville's single-award Blanket Purchase Agreement with the HHS Office of Logistics and Acquisition Operations, a $10M agreement valid through December 31, 2025. The BPA enables streamlined acquisition of biological materials, blood products, media products, laboratory supplies, and medical and scientific equipment for multiple NIH institutes and research centers. Lonza Walkersville has established itself as a critical supplier to federal biomedical and life sciences research institutions, providing specialized products such as cell culture media, cell lines, transfection devices, and advanced scientific instrumentation that support research initiatives across cancer studies, infectious diseases, regenerative medicine, and cellular engineering.
Quick answers
Who was awarded contract HHSN26300454?
HHSN26300454 was awarded to Lonza Walkersville, Inc. by Office of the Director (National Institutes of Health) on January 30, 2015.
How much is contract HHSN26300454 worth?
The government has obligated $3,121 on HHSN26300454.
Is contract HHSN26300454 an order under another contract?
Yes. HHSN26300454 is a BPA call under HHSN263199900049886B, a blanket purchase agreement.
Was contract HHSN26300454 competed?
The extent of competition for HHSN26300454 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award